Qube Research & Technologies (QRT)’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.95M Buy
+65,896
New +$1.89M ﹤0.01% 2334
2020
Q3
– Sell
-8,697
Closed -$1.72M – 1832
2020
Q2
$1.72M Buy
+8,697
New +$1.8M 0.03% 702
2020
Q1
– Sell
-4,138
Closed -$856K – 1341
2019
Q4
$856K Buy
4,138
+2,132
+106% +$394K 0.03% 680
2019
Q3
$306K Buy
+2,006
New +$329K 0.2% 152
2018
Q2
– Sell
-1,830
Closed -$182K – 860
2018
Q1
$182K Buy
+1,830
New +$197K 0.07% 176

Other funds holding LKFT

Qube Research & Technologies (QRT)'s LKFT Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2026: 65,896 shares worth $1.95M. The stake represents ﹤0.01% of the portfolio and ranks #2334 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in LKFT as recently as Q2 2020.

Qube Research & Technologies (QRT) first reported a position in LKFT in Q1 2018 and has held it in 5 quarters since. 66 funds tracked by Wall St. Rank hold LKFT as of Q3 2026.

  • Qube Research & Technologies (QRT) held 65,896 shares of Lakefront Biotherapeutics American Depositary Shares worth $1.95M as of Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2334 holding.
  • Qube Research & Technologies (QRT) first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and has held it in 5 quarters since.
  • 66 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.